Zamira Life Sciences has raised funds
Zamira Life Sciences has completed a fundraising to accelerate growth.
Zamira is focused on providing innovative, research-based solutions to improve the health, well-being and productivity of food-producing animals. Products and services prevent and treat key animal diseases to ensure safe and sustainable food production. They are favorably positioned as a premium brand with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors.
Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise.
Talk to the deal team
Related deals
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Learn moreKaviari has received a minority investment from idiCo
Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.
Learn moreAWC has acquired a significant minority stake in MyFitness
AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.
Learn more